
TRVN
Healthcare · Biotechnology · $431 market cap
$0.0005+0.00 (+25.0%)Nov 13, 9:30 AM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2024
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 7, 2024 | Before the open | -7.75 | -5.79 | +25.3% |
| Aug 8, 2024 | Before the open | -10.12 | -5.75 | +43.2% |
| May 15, 2024 | Before the open | -11.75 | -9.00 | +23.4% |
| Mar 28, 2024 | Before the open | -0.38 | -1.06 | -178.9% |
| Nov 14, 2023 | Before the open | -3.75 | -14.25 | -280.0% |
| Aug 14, 2023 | Before the open | -26.25 | -17.25 | +34.3% |
| May 15, 2023 | Before the open | -24.58 | -20.25 | +17.6% |
| Mar 30, 2023 | Before the open | -1.75 | -0.73 | +58.3% |
| Nov 9, 2022 | Before the open | -52.08 | -58.37 | -12.1% |
| Aug 11, 2022 | Before the open | -64.58 | -56.25 | +12.9% |
| May 11, 2022 | Before the open | -54.17 | -62.50 | -15.4% |
| Mar 31, 2022 | Before the open | -2.50 | -2.00 | +20.0% |
| Nov 15, 2021 | Before the open | -54.17 |
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has…
| -50.00 |
| +7.7% |
| Aug 12, 2021 | Before the open | -45.83 | -56.25 | -22.7% |
| May 6, 2021 | Before the open | -50.00 | -37.50 | +25.0% |
| Mar 9, 2021 | Before the open | -1.50 | -2.00 | -33.3% |
| Nov 2, 2020 | Before the open | -22.92 | -25.00 | -9.1% |
| Aug 10, 2020 | Before the open | -37.50 | -37.50 | 0.0% |
| May 7, 2020 | Before the open | -43.75 | -37.50 | +14.3% |
| Mar 12, 2020 | Before the open | -2.12 | -1.75 | +17.5% |
| Nov 4, 2019 | Before the open | -62.50 | -56.25 | +10.0% |
| Aug 7, 2019 | Before the open | -62.50 | -30.99 | +50.4% |
| May 10, 2019 | Before the open | -56.25 | -37.50 | +33.3% |
| Mar 13, 2019 | Before the open | -1.87 | -2.50 | -33.7% |
| Nov 8, 2018 | Before the open | -81.25 | -37.50 | +53.8% |
| Aug 2, 2018 | Before the open | -79.17 | -83.12 | -5.0% |
| May 3, 2018 | Before the open | -121.87 | -87.12 | +28.5% |
| Mar 7, 2018 | Before the open | -6.68 | -6.00 | +10.2% |